BRPI0910901A2 - composição farmacêutica com bisfosfonato - Google Patents

composição farmacêutica com bisfosfonato

Info

Publication number
BRPI0910901A2
BRPI0910901A2 BRPI0910901A BRPI0910901A BRPI0910901A2 BR PI0910901 A2 BRPI0910901 A2 BR PI0910901A2 BR PI0910901 A BRPI0910901 A BR PI0910901A BR PI0910901 A BRPI0910901 A BR PI0910901A BR PI0910901 A2 BRPI0910901 A2 BR PI0910901A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
bisphosphonate
bisphosphonate pharmaceutical
composition
pharmaceutical
Prior art date
Application number
BRPI0910901A
Other languages
English (en)
Inventor
Holger Petersen
Karen Beltz
Philipp Lustenberger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0910901A2 publication Critical patent/BRPI0910901A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0910901A 2008-04-04 2009-04-02 composição farmacêutica com bisfosfonato BRPI0910901A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08154114 2008-04-04
PCT/EP2009/053965 WO2009121935A2 (en) 2008-04-04 2009-04-02 Pharmaceutical composition with bisphosphonate

Publications (1)

Publication Number Publication Date
BRPI0910901A2 true BRPI0910901A2 (pt) 2015-09-29

Family

ID=40149846

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910901A BRPI0910901A2 (pt) 2008-04-04 2009-04-02 composição farmacêutica com bisfosfonato

Country Status (11)

Country Link
US (1) US20110034418A1 (pt)
EP (1) EP2273980A2 (pt)
JP (1) JP2011516455A (pt)
KR (1) KR20110005837A (pt)
CN (1) CN102046152A (pt)
AU (1) AU2009232033A1 (pt)
BR (1) BRPI0910901A2 (pt)
CA (1) CA2720418A1 (pt)
EA (1) EA201001578A1 (pt)
MX (1) MX2010010943A (pt)
WO (1) WO2009121935A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE539102T1 (de) * 2006-10-31 2012-01-15 Surmodics Pharmaceuticals Inc Kugelförmige polymer-partikel
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
EP2459176B1 (en) 2009-07-31 2017-09-27 Grünenthal GmbH Crystallization method and bioavailability
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
EP2590628A1 (en) * 2010-06-30 2013-05-15 Evonik Corporation Implant processing methods for thermally labile and other bioactive agents and implants prepared from same
IT1401882B1 (it) * 2010-10-01 2013-08-28 Rosa De Nanoparticelle autoassemblanti per il rilascio di bifosfonati nel trattamento di tumori.
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
GB201200868D0 (en) * 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
JO3394B1 (ar) * 2014-07-04 2019-10-20 Osteo Pharma B V تركيبات ومنتجات للاستعمال في علاج كسور وعيوب العظام
JP6563415B2 (ja) * 2014-11-05 2019-08-21 日本酢ビ・ポバール株式会社 フィルムコーティング組成物並びに経口固形製剤及びその製造方法
CN107206120B (zh) * 2014-11-14 2021-06-18 南洋理工大学 生物可吸收性镁复合材料
WO2016081281A1 (en) * 2014-11-17 2016-05-26 Salk Institute For Biological Studies Lipophilic bisphosphonates and methods of use
ES2546566B2 (es) * 2015-07-23 2016-09-14 Universidade De Santiago De Compostela Sistema para la administración de sustancias biológicamente activas preparado por técnicas de espumado empleando gases comprimidos o fluidos supercríticos
KR102564469B1 (ko) 2016-04-14 2023-08-08 삼성전자주식회사 배터리 보호 방법 및 장치
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability
KR20190101408A (ko) * 2017-01-23 2019-08-30 세이비어 라이프텍 코퍼레이션 활성 성분의 미립자 제조
EP3978014A4 (en) * 2019-05-30 2022-11-16 Xiamen University PREPARATION OF RISEDRONATE ZINC MICRONANO ADJUVANTS AND ITS USE AS A VACCINE ADJUVANT

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3626058A1 (de) * 1986-08-01 1988-02-11 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3776880D1 (de) * 1986-11-21 1992-04-02 Ciba Geigy Ag Neue substituierte alkandiphosphonsaeuren.
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
AUPR553701A0 (en) * 2001-06-07 2001-07-12 Royal Alexandra Hospital For Children, The A device for the delivery of a drug to a fractured bone
BR0314362A (pt) * 2002-09-16 2005-07-19 Novartis Ag Método para previnir ou reduzir fraturas secundárias após fratura de quadril
PE20081043A1 (es) * 2006-10-05 2008-09-17 Novartis Ag Composicion farmaceutica que comprende bifosfonatos
WO2009068567A1 (en) * 2007-11-30 2009-06-04 Novartis Ag C2-c5-alkyl-imidazole-bisphosphonates

Also Published As

Publication number Publication date
JP2011516455A (ja) 2011-05-26
CA2720418A1 (en) 2009-10-08
KR20110005837A (ko) 2011-01-19
EP2273980A2 (en) 2011-01-19
WO2009121935A3 (en) 2010-06-03
EA201001578A1 (ru) 2011-06-30
MX2010010943A (es) 2012-09-28
AU2009232033A1 (en) 2009-10-08
CN102046152A (zh) 2011-05-04
WO2009121935A2 (en) 2009-10-08
US20110034418A1 (en) 2011-02-10

Similar Documents

Publication Publication Date Title
LTPA2018014I1 (lt) Farmacinė kompozicija 514
BRPI0910901A2 (pt) composição farmacêutica com bisfosfonato
LTPA2018005I1 (lt) Farmacinė kompozicija
SMT201600259B (it) Composizioni farmaceutiche antibatteriche
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0920521A2 (pt) combinação farmacêutica
RU2493831C3 (ru) Фармацевтические композиции
DE602008002756D1 (de) Bauzusammensetzung
DK3097925T3 (da) Farmaceutisk sammensætning
DK2273984T3 (da) Lipidsammensætning
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
BRPI1004940A2 (pt) composição farmacêutica
EP2381760A4 (en) CORN PROTEIN COMPOSITION
SMT201700095B (is) Composizioni farmaceutiche per inalazione
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0917231A2 (pt) composição
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI1015939A2 (pt) composição farmacêutica
EP2236149A4 (en) MEDICAL COMPOSITION
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0921654A2 (pt) formulação farmacêutica
EP2335669A4 (en) COMPOSITION FOR MEANS FOR DESENSIBILIZING TEETH
BRPI0921313A2 (pt) composição farmaucêutica
PT2209464E (pt) Composição farmacêutica antimalárica

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.